This is an open label, prospective, test of superiority efficacy trial of Ipomea pes-caprae ointment as an add-on therapy in patient with jellyfish dermatitis. Each patient will receive standard medical treatment depend on the severity of the disease. The doctor will divide the dermatitis area of each patient into two parts. Ipomea pes-caprae ointment will be applied as an add-on therapy to the "test area", while the ointment will not be applied to the "control area". Patients will be asked to come for follow up 6 times in the 28-days study period. Primary objective is to compare the healing time of dermatitis in both areas.
The "Test area" and "Control area" are allocated in each participant. We use the Internal Control fashion. The healing time of each area will be collected as an outcome measure.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
54
Ipomea pes-caprae ointment will be applied twice a day as an add-on therapy.
Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University
Bangkok, Thailand
Healing time of the Jellyfish dermatitis lesion (days)
Time frame: Follow up to 28 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.